Guardian Pharmacy Services, Inc. (GRDN) financials — revenue, cash, debt and margins

Guardian Pharmacy Services, Inc. (GRDN) financials — revenue, cash, debt and margins — InspectStocks

Key figures

Trailing twelve months where a flow is involved, latest reported balance where it is not.

Valuation

Market cap: n/a
P/E (TTM): —
Price / sales: —
EV / EBITDA: —
Price / book: —

Cash flow

FCF yield: —
SBC-adjusted FCF yield: —
SBC impact: 11.8%
Stock compensation (TTM): $10.2M

Margins & growth

Profit margin: 4.5%
Operating margin: 5.8%
Quarterly revenue (year on year): 2.2%
Quarterly earnings (year on year): 142.2%

Balance sheet

Cash & investments: $89.8M
Debt: $35.2M
Net cash / (debt): $54.6M

What it owns and what it owes

Both on one scale, because both are money — the bar that is taller is the one that matters.

Cash and debt

Cash & InvestmentsTotal Debt

Cash counts short-term investments, not just the bank balance — technology companies park most of it in marketable securities, and leaving those out understates it several times over. Debt includes lease obligations.

Where the money goes

Cost of RevenueR&D ExpenseSG&A Expense

Only the three costs filers report consistently. Anything a company does not break out sits outside these bands, so the stack is not the whole cost base.

The rest of the series

Not on the overview because five charts is as much as one decision needs — but here in full, on one period switch. Each bar sums the four quarters ending there — a full year, brought up to today.

Total Revenue

$1.46BQ2 2026+0.5%

1Y: +10.31%

Everything the company sold, before any costs. Each bar sums the four quarters ending there — a full year, brought up to today.

EBITDA

$108.8MQ2 2026+8.3%

1Y: +362.99%

Operating profit before depreciation and amortisation — approximated from operating income, because no depreciation tag is reported consistently enough across filers to do better. Treat it as indicative. Each bar sums the four quarters ending there — a full year, brought up to today.

Profit

$65.91MQ2 2026+24.2%4.5% of revenue

1Y: +171.98%

What was left after every cost, including tax. Each bar sums the four quarters ending there — a full year, brought up to today.

Profit margin

4.5%Q2 2026+23.6%

How much of every dollar of sales the company keeps as profit. A grocer keeps a few cents; a software company can keep half. Each point covers the four quarters ending there — a full year, brought up to today.

Free Cash Flow

$86.84M2025+100.8%

No TTM figures — showing Yearly

Cash left over after running and maintaining the business. One bar per fiscal year, as filed. Stops at the last completed year.

About Guardian Pharmacy Services, Inc.

Ticker: GRDN
SEC classification: Retail-Drug Stores and Proprietary Stores (5912)
Listed on: NYSE
Incorporated in: GA
Financial year ends: December 31
Filer size: Accelerated filer

About this data

Everything above comes from Guardian Pharmacy Services, Inc.’s own filings with the SEC, as reported. No estimates, no analyst figures, nothing adjusted.

Not reported by this filer: R&D Expense, Total Operating Expenses, Interest Expense, Profit per share, Shares outstanding, Interest Income, Net Interest Income, Non-interest Income, Non-interest Expense, Deposits, Loans, Short-term Investments, Short-term Borrowings, Borrowings (total), Operating Lease (total), Finance Lease Liabilities (total), Dividends paid, Depreciation, and Amortization of Intangibles. Companies choose which XBRL tags to use, and anything untagged cannot be recovered — so these are blank rather than guessed.